More about
Neurofibromatosis Type
News
November 17, 2023
2 min read
Save
Mirdametinib improves neurofibromatosis type 1-associated plexiform neurofibromas
Positive results from a pivotal phase 2b trial showed mirdametinib significantly improved the outcomes of patients with neurofibromatosis type 1-associated plexiform neurofibromas, SpringWorks Therapeutics announced in a press release.